LOS ANGELES (CN) – A physicians group sued the U.S. FDA, seeking revocation of FDA approval of roflumilast, a drug used to treat chronic obstructive pulmonary disease. The drug, whose
The long wait is finally over for much-anticipated regulations governing disclosure of pharmaceutical company payments to physicians, and on the rights of patients to protect access to their personal health
The U.S. Patent and Trademark Office (USPTO) published interim final rules revising several patent term adjustment (PTA) provisions in view of the AIA Technical Corrections Act of January 14, 2013.
